BOOK
Medical and Advanced Surgical Management of Pelvic Floor Disorders, An Issue of Obstetrics and Gynecology, E-Book
(2016)
Additional Information
Book Details
Abstract
Dr. Iglesia has created an issue devoted to pelvic floor disorders that has a strong focus on the evidence behind current treatments and diagnostic methods. The authors are top experts in their areas and have contributed reviews on the most important topics in pelvic floor disorders, including Stress Urinary Incontinence; Urge Urinary Incontinence; Pelvic Organ Prolapse Native Tissue repairs; Pelvic Organ Prolapse Vaginal and Laparoscopic Mesh; Fecal Incontinence; PFDR Pelvic Floor Disorders Registry; Ultrasound Imaging of the Pelvic Floor; and Childbirth/Pelvic Floor Epidemiology to name a few.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Medical and Advanced Surgical Management \rof Pelvic Floor Disorders | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword: Keeping Informed About Management Options for Pelvic Floor Disorders\r | vii | ||
| Preface: Medical and Advanced Surgical Management of Pelvic Floor Disorders\r | vii | ||
| The Epidemiology of Pelvic Floor Disorders and Childbirth: An Update\r | vii | ||
| Pelvic Organ Prolapse: New Concepts in Pelvic Floor Anatomy\r | vii | ||
| Anatomy of the Vulva and the Female Sexual Response\r | vii | ||
| Stress Urinary Incontinence: Comparative Efficacy Trials\r | viii | ||
| Overactive Bladder\r | viii | ||
| Native Tissue Prolapse Repairs: Comparative Effectiveness Trials\r | viii | ||
| Pelvic Organ Prolapse---Vaginal and Laparoscopic Mesh: The Evidence\r | viii | ||
| Evidence-Based Update on Treatments of Fecal Incontinence in Women\r | ix | ||
| Registries as Tools for Clinical Excellence and the Development of the Pelvic Floor Disorders Registry\r | ix | ||
| Informed Consent for Reconstructive Pelvic Surgery\r | ix | ||
| Ultrasound Imaging of the Pelvic Floor\r | ix | ||
| OBSTETRICS AND GYNECOLOGY CLINICS | x | ||
| FORTHCOMING ISSUES | x | ||
| June 2016 | x | ||
| September 2016 | x | ||
| December 2016 | x | ||
| RECENT ISSUES | x | ||
| December 2015 | x | ||
| September 2015 | x | ||
| June 2015 | x | ||
| Foreword: Keeping Informed About Management Options for Pelvic Floor Disorders \r | xi | ||
| Preface: \rMedical and Advanced Surgical Management of Pelvic Floor Disorders | xiii | ||
| The Epidemiology of Pelvic Floor Disorders and Childbirth | 1 | ||
| Key points | 1 | ||
| PREVALENCE AND PUBLIC HEALTH BURDEN OF PELVIC FLOOR DISORDERS | 2 | ||
| PELVIC FLOOR DISORDERS AS CHRONIC DISEASE | 2 | ||
| PHASE I: PREDISPOSING FACTORS FOR PELVIC FLOOR DISORDERS | 4 | ||
| Genetic Predisposition | 4 | ||
| Race | 5 | ||
| PHASE II: INCITING FACTORS FOR PELVIC FLOOR DISORDERS | 5 | ||
| Mechanism of Injury | 7 | ||
| PHASE III: INTERVENING FACTORS FOR PELVIC FLOOR DISORDERS | 8 | ||
| Age | 8 | ||
| Obesity | 8 | ||
| SUMMARY | 9 | ||
| REFERENCES | 9 | ||
| Pelvic Organ Prolapse | 15 | ||
| Key points | 15 | ||
| INTRODUCTION | 15 | ||
| FUNDAMENTALS OF PELVIC ANATOMY | 16 | ||
| APICAL COMPARTMENT | 17 | ||
| ANTERIOR COMPARTMENT | 19 | ||
| POSTERIOR COMPARTMENT | 21 | ||
| SUMMARY/DISCUSSION | 23 | ||
| ACKNOWLEDGMENTS | 23 | ||
| REFERENCES | 24 | ||
| Anatomy of the Vulva and the Female Sexual Response | 27 | ||
| Key points | 27 | ||
| INTRODUCTION | 27 | ||
| VULVA | 28 | ||
| Mons | 28 | ||
| Labia Majora | 28 | ||
| Labia Minora | 29 | ||
| Vestibule | 29 | ||
| Innervation | 30 | ||
| Vascular Supply | 32 | ||
| CLITORIS | 32 | ||
| Glans, Prepuce, and Frenulum | 32 | ||
| Body and Crura | 34 | ||
| Suspensory Ligament | 34 | ||
| Root | 35 | ||
| Bulbs | 35 | ||
| Innervation | 35 | ||
| Vascular Supply | 36 | ||
| G-SPOT | 36 | ||
| FEMALE SEXUAL RESPONSE | 38 | ||
| Desire | 38 | ||
| Arousal | 38 | ||
| Orgasm | 38 | ||
| Resolution | 39 | ||
| SUMMARY | 39 | ||
| REFERENCES | 39 | ||
| Stress Urinary Incontinence | 45 | ||
| Key points | 45 | ||
| INTRODUCTION | 45 | ||
| NONSURGICAL MANAGEMENT FOR STRESS URINARY INCONTINENCE | 46 | ||
| Weight Loss | 46 | ||
| Bladder Training | 47 | ||
| Pelvic Floor Muscle Therapy Versus No Treatment | 48 | ||
| Pelvic Floor Muscle Therapy Versus Incontinence Pessary | 49 | ||
| SURGICAL MANAGEMENT | 50 | ||
| Retropubic Versus Transobturator Midurethral Sling | 50 | ||
| Fascial Pubovaginal Sling Versus Midurethral Slings | 51 | ||
| Burch Colposuspension Versus Midurethral Sling | 51 | ||
| Fascial Pubovaginal Slings Versus Burch Colposuspension | 53 | ||
| Full-length Midurethral Slings Versus Single-incision Minislings | 54 | ||
| Periurethral Bulking Injections | 54 | ||
| SUMMARY | 55 | ||
| REFERENCES | 55 | ||
| Overactive Bladder | 59 | ||
| Key points | 59 | ||
| INTRODUCTION | 59 | ||
| ETIOLOGY OF OVERACTIVE BLADDER | 60 | ||
| DIAGNOSIS OF OVERACTIVE BLADDER | 60 | ||
| MANAGEMENT OF OVERACTIVE BLADDER | 61 | ||
| Behavioral Modifications and Pelvic Floor Muscle Retraining/Physical Therapy | 61 | ||
| Medications | 62 | ||
| Botulinum Toxin | 63 | ||
| Percutaneous Tibial Nerve Stimulation | 64 | ||
| Sacral Neuromodulation | 65 | ||
| SUMMARY | 66 | ||
| REFERENCES | 66 | ||
| Native Tissue Prolapse Repairs | 69 | ||
| Key points | 69 | ||
| INTRODUCTION | 69 | ||
| DEFINING SUCCESS OF SURGERY FOR PELVIC ORGAN PROLAPSE | 70 | ||
| VAGINAL APEX | 71 | ||
| ANTERIOR COMPARTMENT | 73 | ||
| POSTERIOR COMPARTMENT | 74 | ||
| UTERINE PRESERVATION | 76 | ||
| DISCUSSION | 77 | ||
| REFERENCES | 80 | ||
| Pelvic Organ Prolapse---Vaginal and Laparoscopic Mesh | 83 | ||
| Key points | 83 | ||
| INTRODUCTION | 83 | ||
| BACKGROUND ON ABDOMINAL MESH | 84 | ||
| INTRODUCTION OF MINIMALLY INVASIVE SACRAL COLPOPEXY | 85 | ||
| LEVEL 1 EVIDENCE FOR LAPAROSCOPIC SACROCOLPOPEXY | 85 | ||
| COMPARISON OF SACRAL COLPOPEXY APPROACHES | 85 | ||
| LEVEL 1 EVIDENCE COMPARING ROBOTIC VERSUS LAPAROSCOPIC SACROCOLPOPEXY | 86 | ||
| LAPAROSCOPIC MESH CONCLUSIONS | 87 | ||
| BACKGROUND ON TRANSVAGINAL MESH | 87 | ||
| TRANSVAGINAL MESH FOR ANTERIOR WALL SUPPORT | 88 | ||
| TRANSVAGINAL MESH FOR POSTERIOR PROLAPSE | 89 | ||
| TRANSVAGINAL MESH FOR APICAL AND MULTICOMPARTMENT PROLAPSE | 89 | ||
| TRANSVAGINAL MESH CONCLUSIONS | 90 | ||
| SUMMARY | 90 | ||
| REFERENCES | 91 | ||
| Evidence-Based Update on Treatments of Fecal Incontinence in Women | 93 | ||
| Key points | 93 | ||
| INTRODUCTION | 93 | ||
| MANAGEMENT | 94 | ||
| Dietary Considerations | 94 | ||
| Avoid offending foods | 94 | ||
| Fiber supplementation | 94 | ||
| Medications | 95 | ||
| Pelvic Floor Muscle Exercises and Biofeedback | 97 | ||
| Surgical Management | 97 | ||
| Traditional approaches | 97 | ||
| Sphincteroplasty | 97 | ||
| Special population: obstetric anal sphincter injuries | 98 | ||
| Neosphincter construction | 99 | ||
| Graciloplasty | 99 | ||
| Artificial bowel sphincter | 99 | ||
| Neuromodulation | 100 | ||
| Sacral neurostimulation | 100 | ||
| Percutaneous tibial nerve stimulation | 101 | ||
| Perianal Injectables | 104 | ||
| Radiofrequency Ablation Therapy | 106 | ||
| Fecal Diversion | 107 | ||
| Recently Available Treatment Options: Devices | 107 | ||
| Anal plugs | 107 | ||
| Vaginal bowel control system | 107 | ||
| Investigational Treatment Options | 109 | ||
| Autologous myoblast injection | 109 | ||
| Magnetic anal sphincter | 109 | ||
| Sling for fecal incontinence | 110 | ||
| SUMMARY/DISCUSSION | 111 | ||
| REFERENCES | 111 | ||
| Registries as Tools for Clinical Excellence and the Development of the Pelvic Floor Disorders Registry | 121 | ||
| Key points | 121 | ||
| INTRODUCTION | 121 | ||
| HISTORY OF SURGICAL INNOVATION | 122 | ||
| REGISTRIES: THE POWER OF POOLING DATA | 122 | ||
| INCREASING PREVALENCE OF PELVIC FLOOR DISORDERS | 124 | ||
| SURGICAL TREATMENT OF PELVIC ORGAN PROLAPSE | 124 | ||
| THE COLLAPSE OF THE TRANSVAGINAL MESH AND BUILDING OF NEW BRIDGES | 125 | ||
| BUILDING A UNIVERSAL PELVIC FLOOR DISORDERS REGISTRY | 126 | ||
| SUMMARY | 128 | ||
| REFERENCES | 129 | ||
| Informed Consent for Reconstructive Pelvic Surgery | 131 | ||
| Key points | 131 | ||
| OBJECTIVES | 132 | ||
| INFORMED CONSENT | 132 | ||
| Determining Capacity | 133 | ||
| Freely Consenting | 133 | ||
| Disclosing Information | 133 | ||
| Patient Understanding | 135 | ||
| Decision | 135 | ||
| SURGICAL APPROACH | 135 | ||
| CONTROVERSY OF VAGINAL MESH | 136 | ||
| CURRENT LEGAL ENVIRONMENT | 137 | ||
| SUMMARY | 137 | ||
| REFERENCES | 138 | ||
| Ultrasound Imaging of the Pelvic Floor | 141 | ||
| Key points | 141 | ||
| INTRODUCTION | 141 | ||
| PELVIC FLOOR ANATOMY | 141 | ||
| ULTRASOUND TECHNIQUE | 143 | ||
| Transperineal Ultrasound | 143 | ||
| Endoluminal Ultrasound | 143 | ||
| Endoanal Ultrasound | 144 | ||
| CLINICAL UTILITY | 144 | ||
| Anterior Compartment | 144 | ||
| Central Compartment | 145 | ||
| Posterior Compartment | 145 | ||
| Lateral Compartments | 146 | ||
| Implanted Vaginal Material | 147 | ||
| Endoanal Imaging | 147 | ||
| SUMMARY | 149 | ||
| REFERENCES | 150 | ||
| Index | 155 |